Johnson & Johnson
Close on Nov 2, 2026Market cap $652.02BP/E 31.4Yield 1.90%
Johnson & Johnson TRACLEER [reported separately through FY2019Q4] by Year
TRACLEER (bosentan) [reported separately through FY2019Q4] — U.S. sales ($M) ($M)
Johnson & Johnson TRACLEER [reported separately through FY2019Q4]: $131M in FY2019, down 51.1% from a year earlier. No newer figure appears in the documents we track.
Where the FY2019 figure comes from
Source: Form 10-K (filed 2020-02-18) ↗
Reported in Form 10-Q / 10-K Segment Note & Form 8-K EX-99.2 Segment Sales Schedule.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | TRACLEER (bosentan) [reported separately through FY2019Q4] — U.S. sales ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2019 | Dec 29, 2019 | 131 | -51.1% | Form 10-K (filed 2020-02-18) ↗ |
| FY2018 | Dec 30, 2018 | 268 | +66.5% | Form 10-K (filed 2019-02-20) ↗ |
| FY2017 | Dec 31, 2017 | 161 | – | Form 10-K (filed 2019-02-20) ↗ |
| FY2016 | Jan 1, 2017 | 0 | – | Form 10-K (filed 2019-02-20) ↗ |
Breakdown
What makes up TRACLEER [reported separately through FY2019Q4]
Cite this data
StockData. (2026). Johnson & Johnson TRACLEER [reported separately through FY2019Q4] ($M), annual FY2016–FY2019 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/drug-tracleer-us
See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.